We use cookies to so our web site can function correctly. By Clicking "OK" or by clicking into any content on this site, you agree to allow cookies to be placed. To find out more visit the cookies section of our privacy policy.

Privacy Statement

A cookie is a small file which asks permission to be placed on your computer's hard drive. Once you agree, the file is added and the cookie helps analyse web traffic or lets you know when you visit a particular site. Cookies allow web applications to respond to you as an individual. The web application can tailor its operations to your needs, likes and dislikes by gathering and remembering information about your preferences.

We use traffic log cookies to identify which pages are being used. This helps us analyse data about web page traffic and improve our website in order to tailor it to customer needs. We only use this information for statistical analysis purposes.

Overall, cookies help us provide you with a better website, by enabling us to monitor which pages you find useful and which you do not. A cookie in no way gives us access to your computer or any information about you, other than the data you choose to share with us.

Cookie group mandatory

(Req)
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms.
You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

These cookies are required

Functional

These cookies allow us to adtertise our products to you and allow us to pass this information on to our trusted third parties so that they can advertise our products to you on our behalf
All information these cookies collect is aggregated and therefore anonymous. No personal inforation is shared to third parties. Any personal information collected while using our website could be used for direct marketing from HCA only

Marketing

These cookies allow us to advertise our products to you and allow us to pass this information on to our trusted third parties so that they can advertise our products to you on our behalf
All information these cookies collect is aggregated and therefore anonymous. No personal inforation is shared to third parties. Any personal information collected while using our website could be used for direct marketing from HCA only

Performance Cookies

These cookies allow us to know which pages are the most and least popular and see how visitors move around the site.  All information collect is annonomas unless you provide personal information to us.
If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Professor P Schmid

Professor Peter Schmid

MD, PhD, FRCP

Consultant Medical Oncologist

Specialty
Sub-Specialties
  • Breast cancer, Lung, Small cell lung cancer, Non small cell lung, Other types of lung cancer
Fixed Price Packages

About

  • Biography icon plus

    Peter Schmid is Professor of Cancer Medicine and Lead of the Centre of Experimental Cancer Medicine at Barts Cancer Institute. He is the Clinical Director of the St. Bartholomew Breast Cancer Centre and Honorary Consultant Medical Oncologist at Barts Hospital. He also leads the Cancer Immune Therapy group at Barts Hospital.

    Peter studied medicine in Munich and Aberdeen. He was awarded scholarships by the German National Academic Foundation, the German Academic Exchange Service and the Hanns-Seidel-Foundation. He subsequently completed his specialist training in internal medicine, medical oncology and haematology in Berlin. He undertook an MD in Clinical Chemistry at the Technical University Munich and a PhD in Medical Oncology at the Charité University in Berlin. Peter moved to the UK in 2005 to take on roles as Senior Clinical Lecturer and Director of the Hammersmith Early Clinical Trials Unit at Imperial College London, and subsequently as Foundation Chair in Cancer Medicine at the University of Sussex.

    He focuses his clinical practice on breast cancer, lung cancer and cancer immune therapy. He led the formation of the Cancer Immune Therapy group at Barts Hospital which have become internationally-leading in this rapidly developing field. He has an international reputation for cancer immunotherapy and leads a number of global immunotherapy trials.

    Peter has a particular research interest in triple negative breast cancer and endocrine resistance and has led more than 20 clinical studies and several translational research programmes in these areas. His interests lie in personalised cancer medicine utilising novel biomarkers (for example from bloods samples) and innovative, biomarker-driven clinical trial strategies to develop new treatment strategies. He leads an international group to establish blood-based circulating biomarkers.

    Peter was awarded the Breast Cancer Research Award 2012 by German Patient group Mammazone.

    He is a member of several national and international cancer organisations and research groups and has been involved in international consensus meetings on the management of breast cancer. He is a member of the breast cancer faculty of the European Society of Medical Oncology and has been chair or member of several medical research committees. He has authored or co-authored more than 150 publications and have been an invited speaker and session chair at major European, North American Cancer and Asian cancer conferences. He has published a book on the management of bone metastases (3rd editions).

    Outside his research areas, Peter has a strong interest in patient/doctor communication; for several years, he ran a programme to train oncologists and oncology nurses in communication skills supported by several patient groups.

  • Clinical interests icon plus

    Breast Oncology, Dealing with early breast lumps, Lung cancer, Immunotherapy, Triple negative breast cancer, Clinical Trials

Practice locations

back to top